A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening - PubMed (original) (raw)
A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening
X Saulquin et al. Eur J Immunol. 2000 Sep.
Free article
Abstract
Knowledge of the immunodominant responses to Epstein-Barr Virus (EBV) and human cytomegalovirus (HCMV) should help to generate cytotoxic T cell lines to these herpesviruses. Here we report on the analysis of CD8 T cell responses to EBV and HCMV in the blood of kidney transplant recipients undergoing viral reactivation (n = 16) and in healthy virus carriers (n = 10). We used a transient COS transfection assay that permits semi-quantitative estimation of CD8+ T cell responses against a larger number of HLA/viral protein combinations within polyclonal T cell lines and thus allows a rapid identification of major epitopes. From the comparison of these responses to those that we previously described in the synovial fluid of patients suffering from various forms of chronic arthritis (n = 32), it appears that EBV-specific T cells are mainly directed against a restricted set of immunodominant epitopes, primarily generated during the early lytic cycle and that both IE1 and pp65 are targets of the anti-HCMV response. We suggest that this method could be generally applied to the rapid identification of immunodominant T cell epitopes in viral and tumor immunity, and could help selecting HLA-peptide complexes that could be used to detect and sort specific T cell populations.
Similar articles
- Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C. Rohrlich PS, et al. Hum Immunol. 2004 May;65(5):514-22. doi: 10.1016/j.humimm.2004.02.018. Hum Immunol. 2004. PMID: 15172452 - Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
Nguyen TH, Mifsud NA, Stewart LA, Rose MJ, Etto TL, Williamson NA, Purcell AW, Kotsimbos T, Schwarer AP. Nguyen TH, et al. Protein Expr Purif. 2008 Sep;61(1):22-30. doi: 10.1016/j.pep.2008.05.001. Epub 2008 May 14. Protein Expr Purif. 2008. PMID: 18539483 - Immunodominant CD8 T cell response to Epstein-Barr virus.
Houssaint E, Saulquin X, Scotet E, Bonneville M. Houssaint E, et al. Biomed Pharmacother. 2001 Sep;55(7):373-80. doi: 10.1016/s0753-3322(01)00082-8. Biomed Pharmacother. 2001. PMID: 11669500 Review. - Epstein-Barr virus and rheumatoid arthritis.
Bonneville M, Scotet E, Peyrat MA, Saulquin X, Houssaint E. Bonneville M, et al. Rev Rhum Engl Ed. 1998 Jun;65(6):365-8. Rev Rhum Engl Ed. 1998. PMID: 9670326 Review. No abstract available.
Cited by
- MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
Long HM, Chagoury OL, Leese AM, Ryan GB, James E, Morton LT, Abbott RJ, Sabbah S, Kwok W, Rickinson AB. Long HM, et al. J Exp Med. 2013 May 6;210(5):933-49. doi: 10.1084/jem.20121437. Epub 2013 Apr 8. J Exp Med. 2013. PMID: 23569328 Free PMC article. - Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.
Morice A, Charreau B, Neveu B, Brouard S, Soulillou JP, Bonneville M, Houssaint E, Degauque N. Morice A, et al. PLoS One. 2010 Aug 12;5(8):e12120. doi: 10.1371/journal.pone.0012120. PLoS One. 2010. PMID: 20711433 Free PMC article. - Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.
Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Hislop AD, et al. J Exp Med. 2002 Apr 1;195(7):893-905. doi: 10.1084/jem.20011692. J Exp Med. 2002. PMID: 11927633 Free PMC article. - A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.
Dasari V, Beckett K, Horsefield S, Ambalathingal G, Khanna R. Dasari V, et al. PLoS Pathog. 2022 Jun 23;18(6):e1010403. doi: 10.1371/journal.ppat.1010403. eCollection 2022 Jun. PLoS Pathog. 2022. PMID: 35737741 Free PMC article. - Prospects of a novel vaccination strategy for human gamma-herpesviruses.
Wu TT, Blackman MA, Sun R. Wu TT, et al. Immunol Res. 2010 Dec;48(1-3):122-46. doi: 10.1007/s12026-010-8172-z. Immunol Res. 2010. PMID: 20717741 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials